Clinical Trial Update: Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide with VDDT regimen in relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• VDDT regimen

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN